Loading provider…
Loading provider…
Neurology Physician in Falls Church, VA
NPI: 1306081146Primary Practice Location
INOVA FAIRFAX HOSPITAL
3300 Gallows Rd, Falls Church, VA
Primary Employer
Inova Health Care Services
inova.org
HQ Phone
Get MD Joseph's Phone Numberphone_androidMobile
Get MD Joseph's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
VA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 112 | 116 |
| 2 | 99231Subsequent hospital inpatient care, typically 15 minutes per day | 31 | 41 |
| 3 | 95885Needle measurement and recording of electrical activity of muscles of arm or leg limited study | 24 | 27 |
| 4 | 95886Needle measurement and recording of electrical activity of muscles of arm or leg complete study | 24 | 26 |
| 5 | 99203New patient outpatient visit, total time 30-44 minutes | 22 | 22 |
Authors: David Michelson, Crystal Proud, M Mccormick, Lauren Elman, Terry Heiman-Patterson, Senda Ajroud-Driss, Margaret Frey
Journal: J Neuromuscul Dis
Electrodiagnostic Testing for Disorders of Peripheral Nerves.
Authors: Choi, Joseph M, Di Maria, Gianluca
Journal: Clin Geriatr Med
Publication Date: 2021-03-23
Lead Sponsor: Mitsubishi Tanabe Pharma America Inc.
Collaborators: Massachusetts General Hospital
Intervention / Treatment: DRUG: Edaravone (Radicava®/Radicava ORS®)
Lead Sponsor: Washington University School of Medicine
Intervention / Treatment: DRUG: Observational study to examine safety, tolerability, and effectiveness of SPINRAZA® prescribed as part of standard of care, OTHER: One time survey
Lead Sponsor: Alexion Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Placebo, BIOLOGICAL: Ravulizumab